HL
Helen Louise Collins
DELAYED 1 MONTH
CHIEF MEDICAL OFFICER; Director
Enliven Therapeutics, Inc.
Kura Oncology, Inc.
Filings
3
Companies
2
Latest
Jun 4, 2026
Transactions
Signal
Ticker / Company
Insider
Transaction
Value
Filed
53
Enliven Therapeutics, Inc.
Helen Louise Collins
CHIEF MEDICAL OFFICER
Sale
$199.0K
5,000 sh
May 20 8:18 PM
May 18, 2026
—
Enliven Therapeutics, Inc.
Helen Louise Collins
CHIEF MEDICAL OFFICER
Option Exercise
$12.4K
5,000 sh
May 20 8:18 PM
May 18, 2026
72
Enliven Therapeutics, Inc.
Helen Louise Collins
CHIEF MEDICAL OFFICER
Sale
$305.8K
10,129 sh
Mar 11 9:32 PM
Mar 10, 2026
—
Enliven Therapeutics, Inc.
Helen Louise Collins
CHIEF MEDICAL OFFICER
Option Exercise
$25.1K
10,129 sh
Mar 11 9:32 PM
Mar 10, 2026
72
Enliven Therapeutics, Inc.
Helen Louise Collins
CHIEF MEDICAL OFFICER
Sale
$896.8K
29,871 sh
Mar 11 9:32 PM
Mar 9, 2026
—
Enliven Therapeutics, Inc.
Helen Louise Collins
CHIEF MEDICAL OFFICER
Option Exercise
$74.1K
29,871 sh
Mar 11 9:32 PM
Mar 9, 2026